Market Cap | ₹11,548Cr |
ROE | 42.11% |
P/E Ratio(TTM) | 29.15 |
EPS(TTM) | 172.04 |
P/B Ratio | 13.42 |
Dividend Yield | 2.33% |
Industry P/E | 35.77 |
Book Value | 373.70 |
Debt to Equity | 0.02 |
Face Value | 10 |
Parent Organisation | Sanofi India Limited |
Managing Director | Mr. Rodolfo Hrosz |
NSE Symbol | SANOFI |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Abbott India | NA (0.00%) | 44.20 | ||
GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 49.23 | ||
Pfizer | NA (0.00%) | 28.68 | ||
Astrazeneca Pharma India | NA (0.00%) | 120.77 |